Pazufloxacin 0.6%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pazufloxacin 0.6%, covering 2021-08-24 to 2021-08-24. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%. [Phase 3]